Diagnosis of leukemia using microarray technology;Neue methode zur diagnostik von leukämien: DNA-microarrays

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 42, 2002, Pages 2216-2222

  Kohlmann, A ^a   Schoch, C ^a   Schnittger, S ^a   Kern, W ^a   Haferlach, Torsten ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; IMATINIB;

CANCER CLASSIFICATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA MICROARRAY; GENE EXPRESSION; HUMAN; LEUKEMIA; POLYMERASE CHAIN REACTION; RELIABILITY; REVIEW; TREATMENT OUTCOME;

EID: 18644370386     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34945     Document Type: Review

References (28)

1. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-511
2. Armstrong SA, Staunton JE, Silverman LB et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41-47
3. Ashburner M, Ball CA, Blake JA et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29
4. Brazma A, Hingamp P, Quackenbush J et al. Minimum information about a microarray experiment (MIAME)-toward standards for micro-array data. Nat Genet 2001; 29: 365-371
5. Cobleigh MA, Vogel CL, Tripathy D et al, Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 1999; 17: 2639-2648
6. Duggan DJ, Bittner M, Chen Y, Meltzer P, Trent JM. Expression profiling using cDNA microarrays. Nat Genet 1999; 21 (Suppl 1); 10-14
7. Dysvik B, Jonassen I. J-Express: Exploring gene expression data using Java. Bioinformatics 2001; 17: 369-370
8. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868
9. Enard W, Khaitovich P, Klose J et al. Intra- and interspecific variation in primate gene expression patterns. Science 2002; 296: 340-343
10. Fenaux P, Le Deley MC, Castaigne S et al. European APL 91 Group. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 1993; 82: 3241-3249
11. Golub TR, Slonim DK, Tamayo P et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-537
12. Haferlach T, Schoch C, WHO-Klassifikation der akuten myeloischen Leukäimien (AML) und der myelodysplastischen Syndrome (MDS). Dtsch Med Wochenschr 2002; 127: 447-450
13. Kantarjian H, Sawyers C, Hochhaus A et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002; 346: 645-652
14. Kohlmann A, Dugas M, Schoch C et al. Gene expression profiles of distinct AML subtypes in comparison to normal bone marrow. Blood 2001; 98: 91a
15. Kohlmann A, Dugas M, Schoch C et al. Gene Expression Profiles of Distinct Cytogenetic AML Subtypes as Defined by The New WHO Classification: A Study of 45 Patients. Oncogenomics Conference 2002 http://www.nhgri.nih.gov/CONF/Oncogenomics2002/abstracts.cgi?view=300.
16. Lockhart DJ, Dong H, Byrne MC et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996; 14: 1675-1680
17. Ohyama H, Zhang X, Kohno Y et al. Laser capture microdissection-generated target sample for high-density oligonucleotide array hybridization. Biotechniques 2000; 29: 530-536
18. Phimister B. Oncogenomics: Cancer and technology. Nat Genet 2002; 31: 117-119
19. Pomeroy SL, Tamayo P, Gaasenbeek M et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002; 415: 436-442
20. Ramaswamy S, Tamayo P, Rifkin R et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 2001;98:15149-15154
21. Ramaswamy S, Golub TR. DNA microarrays in clinical oncology. J Clin Oncol 2002; 20: 1932-1941
22. Schoch C, Kohlmann A, Schnittger S et al. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci USA 2002; 99: 10008-10013
23. Southern E, Mir K, Shchepinov M. Molecular interactions on microarrays. Nat Genet 1999; 21 (Suppl 1); 5-9
24. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-5121
25. Virtaneva K, Wright FA, Tanner SM et al. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci USA 2001;98:1124-1129
26. World Health Organization. Classification of Tumours: Pathology & Genetics, IARC Press, Lyon, tumours of haematopoietic and lymphoid tissues. Ed. Jaffe ES, Harris NL, Stein H, Vardiman JW. 2001
27. Yeoh EJ, Ross ME, Shurtleff SA et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133-143
28. Zhan F, Hardin J, Kordsmeier B et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 2002; 99: 1745-1757